BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hauben M, Aronson JK, Ferner RE. Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP). Drug Saf 2016;39:421-32. [DOI: 10.1007/s40264-016-0392-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Voss EA, Boyce RD, Ryan PB, van der Lei J, Rijnbeek PR, Schuemie MJ. Accuracy of an automated knowledge base for identifying drug adverse reactions. J Biomed Inform 2017;66:72-81. [PMID: 27993747 DOI: 10.1016/j.jbi.2016.12.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
2 Xiao C, Li Y, Baytas IM, Zhou J, Wang F. An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence. Sci Rep 2018;8:1806. [PMID: 29379048 DOI: 10.1038/s41598-018-19979-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Slattery J. Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them? Drug Saf 2016;39:371-3. [PMID: 26895343 DOI: 10.1007/s40264-016-0407-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Trinh NTH, Solé E, Benkebil M. Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection. Pharmacoepidemiol Drug Saf 2019;28:370-6. [PMID: 29992679 DOI: 10.1002/pds.4613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Capó-Lugo CE, Kho AN, O'Dwyer LC, Rosenman MB. Data Sharing and Data Registries in Physical Medicine and Rehabilitation. PM R 2017;9:S59-74. [PMID: 28527505 DOI: 10.1016/j.pmrj.2017.04.003] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project. Pharmacoepidemiol Drug Saf 2020;29:993-1000. [PMID: 32133717 DOI: 10.1002/pds.4983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Harpaz R, DuMouchel W, Schuemie M, Bodenreider O, Friedman C, Horvitz E, Ripple A, Sorbello A, White RW, Winnenburg R, Shah NH. Toward multimodal signal detection of adverse drug reactions. J Biomed Inform 2017;76:41-9. [PMID: 29081385 DOI: 10.1016/j.jbi.2017.10.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Khouri C, Nguyen T, Revol B, Lepelley M, Pariente A, Roustit M, Cracowski JL. Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances. Front Pharmacol 2021;12:668765. [PMID: 34122089 DOI: 10.3389/fphar.2021.668765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hauben M, Reynolds R, Caubel P. Deconstructing the Pharmacovigilance Hype Cycle. Clin Ther 2018;40:1981-1990.e3. [PMID: 30545608 DOI: 10.1016/j.clinthera.2018.10.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
10 Kürzinger ML, Schück S, Texier N, Abdellaoui R, Faviez C, Pouget J, Zhang L, Tcherny-Lessenot S, Lin S, Juhaeri J. Web-Based Signal Detection Using Medical Forums Data in France: Comparative Analysis. J Med Internet Res 2018;20:e10466. [PMID: 30459145 DOI: 10.2196/10466] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
11 Malec SA, Wei P, Bernstam EV, Boyce RD, Cohen T. Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance. J Biomed Inform 2021;117:103719. [PMID: 33716168 DOI: 10.1016/j.jbi.2021.103719] [Reference Citation Analysis]
12 Bae JH, Baek YH, Lee JE, Song I, Lee JH, Shin JY. Machine Learning for Detection of Safety Signals From Spontaneous Reporting System Data: Example of Nivolumab and Docetaxel. Front Pharmacol 2020;11:602365. [PMID: 33628176 DOI: 10.3389/fphar.2020.602365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hauben M, Hung EY. Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance. Ther Adv Drug Saf 2016;7:94-101. [PMID: 27298720 DOI: 10.1177/2042098616647955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]